Literature DB >> 18272571

Genital ulcers facilitate rapid viral entry and dissemination following intravaginal inoculation with cell-associated simian immunodeficiency virus SIVmac239.

Andrea M Weiler1, Qingsheng Li, Lijie Duan, Masahiko Kaizu, Kim L Weisgrau, Thomas C Friedrich, Matthew R Reynolds, Ashley T Haase, Eva G Rakasz.   

Abstract

Here we report the results of studies in the simian immunodeficiency virus (SIV)-rhesus macaque model of intravaginal transmission of human immunodeficiency virus type 1 in the setting of genital ulcerative diseases. We document preferential association of vRNA with induced ulcers during the first days of infection and show that allogeneic cells of the inoculum traffic from the vaginal lumen to lymphatic tissues. This surprisingly rapid systemic dissemination in this cell-associated SIV challenge model thus reveals the challenges of preventing transmission in the setting of genital ulcerative diseases and illustrates the utility of this animal model in tests of strategies aimed at reducing transmission under these conditions.

Entities:  

Mesh:

Year:  2008        PMID: 18272571      PMCID: PMC2292998          DOI: 10.1128/JVI.01947-07

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  25 in total

1.  Probability of HIV-1 transmission per coital act in monogamous, heterosexual, HIV-1-discordant couples in Rakai, Uganda.

Authors:  R H Gray; M J Wawer; R Brookmeyer; N K Sewankambo; D Serwadda; F Wabwire-Mangen; T Lutalo; X Li; T vanCott; T C Quinn
Journal:  Lancet       Date:  2001-04-14       Impact factor: 79.321

2.  In vitro models of mucosal HIV transmission.

Authors:  R J Shattock; G E Griffin; G I Gorodeski
Journal:  Nat Med       Date:  2000-06       Impact factor: 53.440

Review 3.  The role of sexually transmitted diseases in HIV transmission.

Authors:  Shannon R Galvin; Myron S Cohen
Journal:  Nat Rev Microbiol       Date:  2004-01       Impact factor: 60.633

4.  Subdominant CD8+ T-cell responses are involved in durable control of AIDS virus replication.

Authors:  Thomas C Friedrich; Laura E Valentine; Levi J Yant; Eva G Rakasz; Shari M Piaskowski; Jessica R Furlott; Kimberly L Weisgrau; Benjamin Burwitz; Gemma E May; Enrique J León; Taeko Soma; Gnankang Napoe; Saverio V Capuano; Nancy A Wilson; David I Watkins
Journal:  J Virol       Date:  2007-01-24       Impact factor: 5.103

5.  Sexual transmission and propagation of SIV and HIV in resting and activated CD4+ T cells.

Authors:  Z Zhang; T Schuler; M Zupancic; S Wietgrefe; K A Staskus; K A Reimann; T A Reinhart; M Rogan; W Cavert; C J Miller; R S Veazey; D Notermans; S Little; S A Danner; D D Richman; D Havlir; J Wong; H L Jordan; T W Schacker; P Racz; K Tenner-Racz; N L Letvin; S Wolinsky; A T Haase
Journal:  Science       Date:  1999-11-12       Impact factor: 47.728

6.  Antibody protects macaques against vaginal challenge with a pathogenic R5 simian/human immunodeficiency virus at serum levels giving complete neutralization in vitro.

Authors:  P W Parren; P A Marx; A J Hessell; A Luckay; J Harouse; C Cheng-Mayer; J P Moore; D R Burton
Journal:  J Virol       Date:  2001-09       Impact factor: 5.103

Review 7.  Recent observations on HIV type-1 infection in the genital tract of men and women.

Authors:  Robert W Coombs; Patricia S Reichelderfer; Alan L Landay
Journal:  AIDS       Date:  2003-03-07       Impact factor: 4.177

8.  Syndromic management of sexually-transmitted infections and behaviour change interventions on transmission of HIV-1 in rural Uganda: a community randomised trial.

Authors:  A Kamali; M Quigley; J Nakiyingi; J Kinsman; J Kengeya-Kayondo; R Gopal; A Ojwiya; P Hughes; L M Carpenter; J Whitworth
Journal:  Lancet       Date:  2003-02-22       Impact factor: 79.321

9.  Human immunodeficiency virus acquisition associated with genital ulcer disease and herpes simplex virus type 2 infection: a nested case-control study in Rakai, Uganda.

Authors:  David Serwadda; Ronald H Gray; Nelson K Sewankambo; Fred Wabwire-Mangen; Michael Z Chen; Thomas C Quinn; Tom Lutalo; Noah Kiwanuka; Godfrey Kigozi; Fred Nalugoda; Mary P Meehan; Rhoda Ashley Morrow; Maria J Wawer
Journal:  J Infect Dis       Date:  2003-10-28       Impact factor: 5.226

10.  Blockade of attachment and fusion receptors inhibits HIV-1 infection of human cervical tissue.

Authors:  Qinxue Hu; Ines Frank; Vennansha Williams; John J Santos; Patricia Watts; George E Griffin; John P Moore; Melissa Pope; Robin J Shattock
Journal:  J Exp Med       Date:  2004-04-12       Impact factor: 14.307

View more
  24 in total

1.  Durable protection from vaginal simian-human immunodeficiency virus infection in macaques by tenofovir gel and its relationship to drug levels in tissue.

Authors:  Charles Dobard; Sunita Sharma; Amy Martin; Chou-Pong Pau; Angela Holder; Zsuzsanna Kuklenyik; Jonathan Lipscomb; Debra L Hanson; James Smith; Francis J Novembre; J Gerardo García-Lerma; Walid Heneine
Journal:  J Virol       Date:  2011-11-09       Impact factor: 5.103

Review 2.  Targeting Trojan Horse leukocytes for HIV prevention.

Authors:  Deborah J Anderson; Joseph A Politch; Adam M Nadolski; Caitlin D Blaskewicz; Jeffrey Pudney; Kenneth H Mayer
Journal:  AIDS       Date:  2010-01-16       Impact factor: 4.177

Review 3.  Barriers to mucosal transmission of immunodeficiency viruses.

Authors:  Brandon F Keele; Jacob D Estes
Journal:  Blood       Date:  2011-05-09       Impact factor: 22.113

Review 4.  Targeting early infection to prevent HIV-1 mucosal transmission.

Authors:  Ashley T Haase
Journal:  Nature       Date:  2010-03-11       Impact factor: 49.962

Review 5.  T cell virological synapses and HIV-1 pathogenesis.

Authors:  Benjamin K Chen
Journal:  Immunol Res       Date:  2012-12       Impact factor: 2.829

6.  Finally, a macaque model for cell-associated SIV/HIV vaginal transmission.

Authors:  Deborah J Anderson
Journal:  J Infect Dis       Date:  2010-08-15       Impact factor: 5.226

Review 7.  The role of dendritic cells in driving genital tract inflammation and HIV transmission risk: are there opportunities to intervene?

Authors:  Muki S Shey; Nigel J Garrett; Lyle R McKinnon; Jo-Ann S Passmore
Journal:  Innate Immun       Date:  2013-11-26       Impact factor: 2.680

8.  PVP-coated silver nanoparticles block the transmission of cell-free and cell-associated HIV-1 in human cervical culture.

Authors:  Humberto H Lara; Liliana Ixtepan-Turrent; Elsa N Garza-Treviño; Cristina Rodriguez-Padilla
Journal:  J Nanobiotechnology       Date:  2010-07-13       Impact factor: 10.435

9.  Complete protection from repeated vaginal simian-human immunodeficiency virus exposures in macaques by a topical gel containing tenofovir alone or with emtricitabine.

Authors:  Urvi M Parikh; Charles Dobard; Sunita Sharma; Mian-er Cong; Hongwei Jia; Amy Martin; Chou-Pong Pau; Debra L Hanson; Patricia Guenthner; James Smith; Ellen Kersh; J Gerardo Garcia-Lerma; Francis J Novembre; Ron Otten; Thomas Folks; Walid Heneine
Journal:  J Virol       Date:  2009-08-05       Impact factor: 5.103

10.  Persistence of HIV-1 receptor-positive cells after HSV-2 reactivation is a potential mechanism for increased HIV-1 acquisition.

Authors:  Jia Zhu; Florian Hladik; Amanda Woodward; Alexis Klock; Tao Peng; Christine Johnston; Michael Remington; Amalia Magaret; David M Koelle; Anna Wald; Lawrence Corey
Journal:  Nat Med       Date:  2009-08-02       Impact factor: 53.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.